Patients and their loved ones are demanding better quality healthcare that is affordable, and more accessible.
We know that as a biopharmaceutical company your provider and payer customers are looking for high quality medicines and solutions that bring value to patients and caregivers.
We work with all biopharmaceutical companies regardless of size and therapeutic area who are committed to advancing the state of healthcare quality.
I am responsible for leading our launch readiness team and optimizing our product value proposition with health plans. I’ll need to account for healthcare quality and the shift to value-based care.
I could use help in developing value-based marketing strategies that deliver better outcomes for patients and our business.
I want to help lead my team to better understand relevant aspects of value-based care outcomes in the form of quality measurement.
Specifically, how this relates to evolving our Clinical Development evidence generation strategy to support strong market access earlier in the product development life cycle.
My team could benefit from strategic support and education on healthcare quality and value-based care specific to our therapeutic areas.
This will help support the ability of Medical Science Liaisons to effectively engage with health system and provider stakeholders.
For our biologic specialty medications, we can use help with optimizing engagement with patient advocates and policymakers to establish patient-centric, innovative value-based financing arrangements with principles centered on affordability, lower healthcare costs, patient-centered care, and improved outcomes.
Senior Director, Quality
We need assistance with building strong strategic linkages with key stakeholders to increase the diversity of patients in clinical trials and reduce health inequities in our prioritized disease areas.
This will help improve patient access, care, and outcomes and allow us to meet our business objectives in Value, Access, and Evidence.
I am responsible for establishing the business operating model for provider-based digital health solutions in our company’s therapeutic areas.
With value-based care as a significant driver for digital health, we can use help with better understanding the role of health data interoperability and quality measurement in digital health, how this affects our business strategy, and our health system customers’ unmet needs.
You will receive unique value-based care insights relevant to your business so you can optimize your product value proposition with prioritized provider and payer customers.
You will become a trusted partner and identify opportunities for strategic engagement with external stakeholders who focus on Quintuple Aim outcomes (improving population health, enhancing patient & care team experiences, reducing costs, and advancing health equity).
You will gain insights on how to cultivate win-win relationships with prioritized external stakeholders to achieve mutual strategic goals that improve care delivery and health outcomes, lead to better patient experiences, achieve equity, and reduce costs.
This offering gives you an opportunity to see where we can provide tangible value to a challenge you face. DSO is the easiest way for you to work with us. It represents a starting point.
We meet you where you are. We support customized variations of CQE depending on your goals and needs. Let’s have a conversation about what works best for you.
We will advise you every step of the way. Access our strategic advisory consulting services from THCQ Consulting President & CEO, Norris Turner, PharmD, PhD and others on the THCQ Consulting team on an as-needed basis for the term of the agreement.
Tripp Logan, PharmD
Gerald E. Finken
Chief Executive Officer, RxE2
Our mission is at the
core of what we do
Our mission is to deliver market-relevant strategic guidance for our biopharmaceutical clients by helping to deepen their understanding of their customer’s healthcare quality and value-based care perspectives.
From Lab to Market: The Intersection of Science and Commercial Strategy
In this blog post, we’ll explore how the intersection of evidence-based laboratory and clinical science and strategic commercialization efforts is key for life science company success.